Givaudan Q1 Sales Rise; Sees Organic Sales Growth In FY25 - Quick Facts

Givaudan (GVDBF.PK), a Swiss manufacturer of fragrance and flavor products, reported Tuesday that its first-quarter sales were 1.67 billion Swiss francs, up 3.4 percent from last year's 1.62 billion francs. Sales grew 7.7 percent on a like-for-like basis.

Fragrance & Beauty sales were 788 million francs, up 5.8 percent in Swiss francs and up 9.9 percent on a like-for-like basis. Taste & Wellbeing sales were 886 million francs, an increase of 1.3 percent in Swiss francs. Like-for-like sales increased 5.8 percent.

The good growth was achieved across most product segments and geographies. High growth markets recorded sales growth of 14.5 percent on a like-for-like basis.

CEO Gilles Andrier said, "We have seen continued strong demand across the parts of our business which are less impacted by the COVID-19 pandemic and improving conditions in the parts of our portfolio which have been more affected."

Looking ahead for fiscal 2025, the company said it aims to achieve organic sales growth of 4-5 percent on a like-for-like basis and free cash flow of at least 12 percent, both measured as an average over the five-year period strategy cycle.

The companies ambitions include doubling its business through creations that contribute to happier, healthier lives by 2030, becoming climate positive before 2050, becoming a leading employer for inclusion before 2025 and sourcing all materials and services in a way that protects the environment and people by 2030.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Alexander & Hornung, a business unit of Perdue Premium Meat Co., Inc., is recalling around 234,391 pounds of fully cooked pork products citing possible contamination with Listeria monocytogenes, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. The recall involves ham and pepperoni products that come under various brands and produced on various dates. Sandoz, Inc., an unit of Novartis AG, is recalling one lot of deep vein thrombosis (DVT) medication Enoxaparin Sodium in the form of injection for the potential exposure to high temperatures that may have impacted product effectiveness, the U.S. Food and Drug Administration or FDA said in a statement. Livia Global, Inc., a health and wellness company, is recalling two lots of its Liviaone liquid probiotics citing the possibility of contamination by Pseudomonas aeruginosa, the U.S. Food and Drug Administration said. Pseudomonas aeruginosa is a microorganism found in the environment that, if ingested, can cause life-threatening infection in immunocompromised individuals.
Follow RTT